Which company was the first to receive FDA approval for a CRISPR-based therapy for human genetic disease treatment?

CRISPR gene-editing technology represents one of the most significant scientific breakthroughs of the 21st century, with profound implications for medicine, agriculture, and biotechnology. Since its commercial development, CRISPR has transformed from a laboratory tool into various marketable products and services. This poll tests your knowledge about the commercialization and product development timeline of this revolutionary technology.

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

Vertex Pharmaceuticals and CRISPR Therapeutics (for CASGEVY/exa-cel)
Editas Medicine (for EDIT-101)
Intellia Therapeutics (for NTLA-2001)
Beam Therapeutics (for BEAM-101)